Activation of vitamin D receptor by the Wilms' tumor gene product mediates apoptosis of renal cells

Journal of the American Society of Nephrology

Volumn 12, Issue 6, 2001, Pages 1188-1196

  Wagner, Kay Dietrich ^a   Wagner, Nicole ^a   Sukhatme, Vikas P ^b   Scholz, Holger ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; MESSENGER RNA; TRANSCRIPTION FACTOR; VITAMIN D RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO CELL; GENE EXPRESSION REGULATION; GENE SEQUENCE; HUMAN; HUMAN CELL; KIDNEY CELL; KIDNEY DEVELOPMENT; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TISSUE LEVEL;

EID: 0035023121     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Hastie ND: The genetics of Wilms' tumor - A case of disrupted development. Annu Rev Genet 28: 523-558, 1994
2. Beckwith JB, Kiviat NB, Bonadio JF: Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms' tumor. Pediatr Pathol 10: 1-36, 1990
3. Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman D, Jaenisch R: WT-1 is required for early kidney development. Cell 74: 679-691, 1993
4. Rauscher FJ III: The WT1 Wilms tumor gene product: A developmentally regulated transcription factor in the kidney that functions as a tumor suppressor. FASEB J 7: 896-903, 1993
5. Cook DM, Hinkes MT, Bernfield M, Rauscher FJ III: Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1. Oncogene 13: 1789-1799, 1996
6. Englert C, Maheswaran S, Garvin AJ, Kreidberg J, Haber DA: Induction of p21 by the Wilms' tumor suppressor gene WT1. Cancer Res 57: 1429-1434, 1997
7. Guan LS, Rauchman M, Wang ZY: Induction of Rb-associated protein (RbAp46) by Wilms' tumor suppressor WT1 mediates growth inhibition. J Biol Chem 273: 27047-27050, 1998
8. Larsson SH, Charlieu JP, Miyagawa K, Engelkamp D, Rassoulzadegan M, Ross A, Cuzin F, van Heyningen V, Hastie ND: Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing. Cell 81: 391-401, 1995
9. Drummond IA, Madden SL, Rohwer-Nutter P, Bell GI, Sukhatme VP, Rauscher FJ III: Repression of the insulin-like growth factor gene by the Wilms tumor suppressor WT1. Science 257: 674-678, 1992
10. Ryan G, Steele-Perkins V, Morris JF, Rauscher FJ III, Dressler G: Repression of Pax-2 by WT1 during normal kidney development. Development 121: 867-875, 1995
11. Lee SB, Huang K, Palmer R, Truong VB, Herzlinger D, Kolquist KA, Wong J, Paulding C, Yoon SK, Gerald W, Oliner JD, Haber DA: The Wilms tumor suppressor WT1 encodes a transcriptional activator of amphiregulin. Cell 98: 663-673, 1999
12. Hosono S, Gross I, English MA, Hajra KM, Fearon ER, Licht JD: E-cadherin is a WT1 target gene. J Biol Chem 275: 10943-10953, 2000
13. Reddy JC, Licht JD: The WT1 Wilms' tumor suppressor gene: How much do we really know? Biochim Biophys Acta 1287: 1-28, 1996
14. Thäte C, Englert C, Gessler M: Analysis of WT1 target gene expression in stably transfected cell lines. Oncogene 17: 1287-1294, 1998
15. Pritchard-Jones K, Fleming S, Davidson D, Bickmore W, Porteous D, Gosden C, Bard J, Buckler A, Pelletier J, Housman D, van Heyningen V, Hastie ND: The candidate Wilms' tumour gene is involved in genitourinary development. Nature 346: 194-197, 1990
16. Englert C, Hou X, Maheswaran S, Bennett P, Ngwu C, Re GG, Garvin AJ, Rosner MR, Haber DA: WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis. EMBO J 14: 4662-4675, 1995
17. Coles HSR, Burne JF, Raff MC: Large scale normal cell death in the developing rat kidney and its reduction by epidermal growth factor. Development 118: 777-784, 1993
18. Koseki C, Herzlinger D, Al-Awqati Q: Apoptosis in metanephric development. J Cell Biol 119: 1327-1333, 1992
19. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH, Dominguez CE, Jurutka PW: The nuclear vitamin D receptor: Biological and molecular regulatory properties revealed. J Bone Miner Res 13: 325-349, 1998
20. Jehan F, DeLuca HF: Cloning and characterization of the mouse vitamin D receptor promoter. Proc Natl Acad Sci USA 94: 10138-10143, 1997
21. Miyamoto KI, Kesterson RA, Yamamoto H, Taketani Y, Nishiwaki E, Sawako T, Inoue Y, Morita K, Takeda E, Pike JW: Structural organization of the human vitamin D receptor chromosomal gene and its promoter. Mol Endocrinol 11: 1165-1179, 1997
22. 3. Crit Rev Eukaryot Gene Expr 8: 19-42, 1998
23. 3: Receptor ontogenesis in fetal renal development. Am J Physiol 38: F419-F428, 1995
24. Buckler AJ, Pelletier J, Haber DA, Glaser T, Housman DE: The murine Wilms' tumor gene (WT1): Isolation, characterization, and expression during kidney development. Mol Cell Biol 11: 1707-1712, 1991
25. Gorman C, Moffat LF, Howard BH: Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol 2: 1044-105, 1982
26. Wang ZY, Qiu QQ, Huang J, Gurrieri M, Deuel TF: WT1, the Wilms' tumor suppressor gene product, represses transcription through an interactive nuclear protein. Oncogene 10: 415-422, 1995
27. Drummond IA, Mukhopadhyay D, Sukhatme VP: Expression of fetal kidney growth factors in a kidney tumor line: Role of FGF2 in kidney development. Exp Nephrol 6: 522-533, 1998
28. Haber DA, Sohn PL, Buckler AJ, Pelletier J, Call KM, Housman DE: Alternative splicing and genomic structure of the Wilms tumor gene WT1. Proc Natl Acad Sci USA 88: 9618-9622, 1991
29. Scholz H, Bossone SA, Cohen HT, Akella U, Strauss WM, Sukhatme VP: A far upstream cis-element is required for Wilms' tumor-1 (WT1) gene expression in renal cell culture. J Biol Chem 272: 32836-32846, 1997
30. 3 by leukemic cells. J Steroid Biochem Mol Biol 57: 117-124, 1996
31. 3: increases epidermal growth factor receptors and transforming growth factor beta-like activity in a bone-derived cell line. J Biol Chem 262: 13424-13428, 1987
32. Liu M, Lee MM, Cohen M, Bommakanti M, Freedman LP: Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 10: 142-153, 1996
33. Reddy JC, Hosono S, Licht JD: The transcriptional effect of WT1 is modulated by choice of expression vector. J Biol Chem 270: 29976-29982, 1995
34. Ernstsson S, Pierrou S, Hulander M, Cederberg A, Hellqvist M, Carlsson P, Enerbäck S: Characterization of the human forkhead gene FREAC-4. J Biol Chem 271: 21094-21099, 1996
35. Johnstone RW, See RH, Sells SF, Wang J, Muthukkumar S, Englert C, Haber DA, Licht JD, Sugrue SP, Roberts T, Rangnekar VM, Shi Y: A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1. Mol Cell Biol 16: 6945-6956, 1996
36. Maheswaran S, Park S, Bernard A, Morris JF, Rauscher FJ, Hill DE, Haber DA: Physical and functional interaction between WT1 and p53 proteins. Proc Natl Acad Sci USA 90: 5100-5104, 1993
37. Veis D, Sorenson C, Shutter J, Korsmeyer S: Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75:229-240, 1993
38. 3 cytotoxicity in a rat glioma resistant clone. J Neurosci Res 52: 210-219, 1998
39. 3: and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death. Cancer Res 60: 2040-2048, 2000
40. Li YC, Pirro AE, Amling M, Delling G, Baron R, Bronsson R, Demay MB: Targeted ablation of the vitamin D receptor: An animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci USA 94: 9831-9835, 1997
41. Yoshizawa T, Handa Y, Uematsu Y, Takeda S, Sekine K, Yoshihara Y, Kawakami T, Arioka K, Sato H, Uchiyama Y, Masushige S, Fukamizu A, Matsumoto T, Kato S: Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet 16: 391-396, 1997
42. Luetteke NC, Qiu TH, Fenton SE, Troyer KL, Riedel RF, Chang A, Lee DC: Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. Development 126: 2739-2750, 1999